Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Biondi

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 16, 2025
Peginterferon λ for the treatment of patients admitted to hospital with COVID-19: a phase 2, placebo-controlled randomized trialChristopher Kandel, Mia J Biondi, Mark Gillrie, et al.
The Lancet. Respiratory Medicine|February 8, 2021
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trialJordan J Feld, Christopher Kandel, Mia J Biondi, et al.
The New England Journal of Medicine|February 13, 2023
Early Treatment with Pegylated Interferon Lambda for Covid-19Gilmar Reis, Eduardo A S Moreira Silva, Daniela C Medeiros Silva, et al.
Microorganisms|March 3, 2021
Characterization of Ebola Virus Risk to Bedside Providers in an Intensive Care EnvironmentMia J Biondi, Lauren Garnett, Alexander Bello, et al.
Journal of Hepatology|April 8, 2023
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countriesHomie A Razavi, Maria Buti, Norah A Terrault, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 16, 2025
Peginterferon λ for the treatment of patients admitted to hospital with COVID-19: a phase 2, placebo-controlled randomized trialChristopher Kandel, Mia J Biondi, Mark Gillrie, et al.
The Lancet. Respiratory Medicine|February 8, 2021
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trialJordan J Feld, Christopher Kandel, Mia J Biondi, et al.
The New England Journal of Medicine|February 13, 2023
Early Treatment with Pegylated Interferon Lambda for Covid-19Gilmar Reis, Eduardo A S Moreira Silva, Daniela C Medeiros Silva, et al.
Microorganisms|March 3, 2021
Characterization of Ebola Virus Risk to Bedside Providers in an Intensive Care EnvironmentMia J Biondi, Lauren Garnett, Alexander Bello, et al.
Journal of Hepatology|April 8, 2023
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countriesHomie A Razavi, Maria Buti, Norah A Terrault, et al.
Pageof 7